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Constitutive Activation of c-kit in FMA3 Murine Mastocytoma Cells Caused by Deletion of Seven Amino Acids at the Juxtamembrane Domain
By Tohru Tsujimura, Masahiro Morimoto, Koji Hashimoto, Yasuhiro Moriyama, Hitoshi Kitayama, Yuji Matsuzawa, Yukihiko Kitamura, and Yuzuru Kanakura A peculiar point mutation results in constitutive activation of c-kitreceptor tyrosine kinase (KIT) in three different tumor mast cell lines; ie, the HMC-1, P-815, and RBL-2H3. Because constitutive activation of KIT was also observed in the FMA3 mouse mastocytoma cell line, we investigated the molecular mechanism. Sequencing of the whole coding region of the c-kit showed that the point mutation found in HMC-1, P-815, and RBL-2H3 cells was absent in FMA3 cells and that the ckit cDNA of FMA3 cells carried an in-frame deletion of 21 base pairs (bp) encoding Thr-Gln-Leu-Pro-Tyr-AspHis at codons 573 t o 579 at the juxtamembrane domain. The FMA3-type c-kitcDNA with 21 bp deletion was introduced into the IC-2 cell line, which was derived from murine cultured mast cells. IC-2 cells were dependent on interleukin (ILI-3 and did HE PROTO-ONCOGENE c-kit encodes a receptor tyrosine kinase (RTK) that is a member of the same RTK subfamily (type I11 RTK) as the receptors for platelet-derived growth factor (PDGF) and colony-stimulating factor-l (CSFl).'*2 This RTK subfamily is characterized by the presence of five Ig-like repeats in the extracellular domain and an insert that splits the cytoplasmic kinase domain into the adenosine triphosphate (ATP)-binding and phosphotransferase regions.'" The c-kit gene is allelic with the dominant-spotting (W) locus on mouse chromosome 5, whereas the ligand for c-kit RTK (KIT) is genetically mapped at the steel (SI) locus on mouse chromosome 10 and is variously designated as stem cell factor (SCF), mast cell growth factor, kit ligand, or steel f a~t o r .~"~ On SCF binding, KIT is dimerized and its intrinsic tyrosine kinase is activated, resulting in transphosphorylation at critical tyrosine residues. The phosphorylated KIT can then bind a unique array of intracellular signaling molecules, including phosphatidylinositol 3 '-kinase, phospholipase C-y 1, and hematopoietic cell phosphatase, thereby initiating a signaling cascade that leads to various cellular responses.16-" This KIT-mediated signal transduction is known to play a crucial role in proliferation, differentiation, migration, and survival of hematopoietic stem cells, mast cells, melanocytes, and germ cells. In fact, loss-of-function mutations at KITIW locus give rise to depletion of erythrocytes, mast cells, melanocytes, and germ Like many other RTKs, the c-kit proto-oncogene was first identified as retroviral oncogene (v-kit) present in the genome of the HZ4 feline sarcoma virus:' suggesting that KIT might potentially function as an oncogenic protein especially by structural alterations. Among various types of leukemia cells t e~t e d , '~.~~ KIT was constitutively activated in a ligandindependent manner in the HMC-l human mast cell leukemia cell line.24 Sequencing analysis of c-kit gene in HMCl cells showed two point mutations, the Val5@' to Gly5@' mutation in the juxtamembrane domain and the Asp8I6 to mutation in the phosphotransferase domain. Transfection of murine kit"^'^^ or c-kitVar8"' mutants, corresponding to human c-kitcry560 or c-kitVa'8'6 genes, into 293T human embryonic kidney derived cells resulted in a ligand-independent activation of or KITV" '14 . 24 In addition, we have recently found that both the P-815 mouse mastocytoma cell line and the RBL-2H3 rat mast cell leukemia cell line carried constitutively activating mutations of c-kit gene in the corresponding Asp codon in the phosphotransferase dowere introduced into cells of murine interleukin (IL)-3-dependent cell lines, the expression of or with constitutive tyrosine kinase activity not only abrogated IL-3 requirement of the cells, but also caused them to become tumorigenic in nude athymic mice?' These results suggested that the similar or as-yet-unidentified mutations of c-kit might be involved in neoplastic growth of mast cells.
The FMA3 mouse mastocytoma cell line is used for studying biology and biochemistry of mast cells as frequently as HMC-1, P-815, and RBL-2H3 cells.28329 Despite their frequent use of the FMA3 cell line, molecular mechanism of its neoplastic growth has not been clarified. In the present study, we examined whether KIT was constitutively activated in FMA3 cells and found that it was the case. However, we did not find the point mutations that have been identified in HMC-1, P-815 and RBL-2H3 cells. Instead of the point mutations, a deletion of seven amino acids was found at the juxtamembrane domain of KIT obtained from FMA3 cells. main.25.26 When the murine c-kitcry559 or kit"^'^'^ mutants (sulfo-succinimidy1)suberate (BS') from Pierce (Rockford, IL).
Cells and mice. The FMA3 cell line was generously given by Dr H. Hasegawa (The Nishi-Tokyo University, Yamanashi, Japan). FMA3 cells were adapted to grow in a-minimal essential medium (0-MEM, ICN Biomedicals, Costa Mesa, CA) supplemented with 10% fetal calf serum (FCS, Nippon Bio-Supp. Center, Tokyo, Japan). Pokeweed mitogen-stimulated spleen cell conditioned medium (PWM-SCM) was prepared according to the method described by Nakahata et al." Cultured mast cells (CMCs) were obtained by culturing spleen cells of C57BL/6-+/+ mice (+/+ CMCs) with a-MEM supplemented with 10% PWM-SCM and 10% FCS.34 The 293T cell line was derived from human embryonic kidney cells transformed by DNA from human adenovirus type 5 and was provided by Dr D. Baltimore (Rockefeller University, New York, NY)." 293T cells were maintained in Dulbecco's modification of Eagle's medium (DMEM, ICN Biomedicals) supplemented with 10% FCS. IC-2, a murine IL-3-dependent mast cell line," was provided by Dr I. Yahara (The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), and maintained with a-MEM supplemented with IO% PWM-SCM and IO% FCS. A helper virus-free q 2 packaging cell lineT7 was maintained in DMEM supplemented with 10% FCS. Nude atbymic mice of BALBlc-nulnu were purchased from Japan SLC. Inc (Hamamatsu, Japan) and were kept under specific-pathogen-free conditions. All nude athymic mice were female and were 8 weeks of age at the time of cell injection. with a test wavelength of 540 nm and a reference wave length of 620 nm.
Immunoprecipitation and immunoblotting. The procedures of cell lysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were performed according to the methods described p r e v i o~s l y . '~~~~~" ' .~' Briefly, after the depletion o f serum and factors, 1.0 X IO' cells were suspended in 1 mL of a-MEM and were exposed to 100 ng/mL of rmSCF for 15 minutes at 37°C. Cells were then lysed in lysis buffer (20 mmol/L Tris-HCI.
137 mmol/L NaC1, 10% glycerol, 1% Nonidet P-40, pH 8.0, and protease and phosphatase inhibitors) at 4°C for 20 minutes. The extracts were precipitated with ACK2 MoAb and Protein-G Sepharose beads (Pharmacia, Uppsala, Sweden). The immunoprecipitates were subjected to SDS-PAGE with 5% to 20% gradient polyacrylamide. Proteins were electrophoretically transferred from the gel onto a polyvinylidene difluoride membrane (Immobilon, Millipore Corp, Bedford, MA), and immunoblotting was performed with antiphosphotyrosine MoAb.
Immune complex kinase assay. The immune complex kinase assay was performed according to the method described prebuffer, and incubated for 45 minutes at 4°C with rabbit antiserum against a C-terminal peptide corresponding to the last 10 amino acids of the murine KIT and Protein-G Sepharose beads to collect the antigen-antibody complexes. After washing, the immune complexes were incubated in kinase buffer ( I 0 mmol/L MnCl', 20 mmol/L Tris-HCI, pH 7.4) containing 1 pL of y-["PI-ATP (DuPont/NEN Research Products, Boston, MA; 10 mCi/mL) for 20 minutes at 25°C and separated by SDS-PAGE with 5% to 20% grsdient polyacrylamide. The gel was dried, and radioactive proteins were detected by autoradiography.
Oligonucleotide primers. To isolate c-kif cDNA fragments from Prepmution o f RNA and genomic DNA. Total RNA was extracted from +/+ CMCs and FMA3 cells by lithium chloride-urea method.3" Genomic DNA was prepared from the +/+ CMCs and FMA3 cells by the standard m e t h~d .~" cDNA synthesis, PCR ampl$cation, sequencing qf c-kit cDNA. From 5 p g of total RNA, the single-strand cDNA was synthesized using reverse transcriptase and downstream antisense primers. cDNA synthesized from 5 p g of total RNA or genomic DNA ( I O ng) was amplified by PCR using Taq DNA polymerase in 30 cycles of 1-minute denaturation at 94°C 2-minute annealing at %"C, 3-minute synthesis at 72°C. For the analysis of cDNA sequence. products vioUsly,'"?h.lX Briefly, the cell lysates were prepared by using lysis only.
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of reverse transcriptase modification of PCR (RT-PCR) were gelpurified, treated with T4 polynucleotide kinase and Klenow fragment of DNA polymerase I, subcloned into the EcoRV site of Bluescript I KS(-). Nucleotide sequence was determined by Model 373A DNA sequencer (Applied Biosystems, Foster, CA) using Taq dye deoxyterminator cycles sequencing kit (Applied Biosystems)!'
Construction of transgene and retroviral transfer. The gene encoding murine wild-type (WT) c-kit cDNA (hereafter called c-kitw cDNA) was cloned into an EcoRV site of Bluescript I KS(-). Three differences had been found between the presently used c-kitwcDNA and the published c-kit sequence of BALB/c nice:'.^'.^' an AT to CC transversion at nucleotide 648 that resulted in the amino acid substitution of Glu to Ala at codon 207; a CC to TA transition at nucleotide 1618 that did not induce alteration of amino acids; and a GCG codon at nucleotides 2357 to 2359 changed to a GGC codon, leading to the change from Ala to Gly at codon 777. Because the first and third changes were observed in c-kit cDNA derived from C3H-+/+42 and C57BW6-+/+ mice43 as well, they are considered to be strain-specific polymorphisms. The DraI-NdeI fragment (nucleotide 1559 to 1854) of c-kitw cDNA was exchanged for the corresponding fragment of c-kit cDNA obtained from FMA3 cells. The resulting c-kit cDNA had 21-bp deletion at nucleotide 1745 to 1765 and was designated as c-kifMA3 cDNA. The full coding sequences of d i t w cDNA or c-kifMA' cDNA were released by digestion of HindIII and SmaI restriction enzymes and isolated. The HindIIISmaI fragments were inserted into a HindIII-SmaI site of expression vector pSV2ne0.~ The expression vectors containing c-kitw cDNA or c-kifMA3 cDNA were transfected into 293T cells by the calcium phosphate method as described previously!'
A retroviral vector pM5Gne0,~ a derivative of myeloproliferative sarcoma virus, was a kind gift from Dr W. Ostertag of Hamburg University, Hamburg, Germany. Packaging cells producing pM5Gneo and pM5Gneo-ckitw virus have already been prepared in our l a b o r a t~r y .~~ Packaging cells producing pM5Gneo-c-kifMA3 virus were prepared as described previou~ly.~~ For gene transfer, IC-2 cells (lo') were incubated on irradiated (30.0 Cy) subconfluent monolayer of virus-producing packaging cells for 48 hours in a-MEM containing 10% PWM-SCM and 10% FCS. Infected cells were selected by culturing in medium containing G418 (1.0 mg/mL) for at least 3 weeks. The resulting IC-2 cells which expressed pM5Gne0, pM5Gneo-c-kitw, or pM5Gneo-c-kifMA3 virus were named as IC-2VECT0R, IC-2wT, or ICChemical cross-linking. Dimerization of KIT was analyzed by chemical cro~s-linking.~' IC-2w or FMA3 cells were washed in PBS containing 1 mg/mL bovine serum albumin. Cells were incubated with or without rmSCF (300 ng/mL) for 90 minutes at 4"C, and were then washed five times in ice-cold PBS. Cross-linking was performed in PBS with BS3 (1 mmollL) for 30 minutes at 22°C. The reaction was stopped by adding glycine-HC1 (pH 7.5) to the final concentration of 150 mmol/L and incubating for 5 minutes at 4°C. Sodium orthovanadate (100 pmoVL) was included in all buffers to prevent dephosphorylation of KIT. Cells were lysed in lysis buffer. The lysates were immunoprecipitated with the Ab-1 rabbit polyclonal antibody. The immunoprecipitates were subjected to SDS-PAGE with 4% polyacrylamide. Proteins were electrophoretically transferred from the gel onto a polyvinylidene difluoride membrane, and immunoblotting was performed with the murine antiphosphotyrosine MoAb. The membrane was then incubated with horseradish peroxidase-conjugated goat antimouse IgG antibody (Cappel Research Products, Durham, NC). The KIT phosphorylated on tyrosine residues was then visualized by Renaissance chemiluminescence reagent (Dupont).
sulfo-NHS-biotin (Pierce Chemical Company) according to the 2FMA3 cells, respectively.
Labeling with sulfo-NHS-biotin. Cells were surface-labeled by method described by Ishihara et aI?* Briefly, cells were incubated with labeling buffer [ 100 m o V L N-(2-hydroxyethyl) piperazine-N'-(2-ethanesulfonic acid), pH 8.0, 150 mmoVL NaCl] containing sulfo-NHS-biotin (0.1 mg/mL) at room temperature for 30 minutes. Labeled cells were washed twice with RPMI 1640 (Nikken Bio Medical Laboratory, Kyoto, Japan) containing 3% FCS and incubated in either 1 mL RPMI 1640 containing 10% FCS or 1 mL RPMI 1640 containing 10% FCS and rmSCF (10 ng/mL) at 37°C for 15 minutes. At 0, 15, 30, and 60 minutes after the incubation, labeled cells were washed with cold PBS and lysed in lysis buffer (20 mmol/L Tris-HCI, pH 8.0, 137 mmoVL NaCl, 10% glycerol, 1% Nonidet P-40 containing protease and phosphatase inhibitors). Insoluble materials were removed by centrifugation. For immunoprecipitation, the lysates of unstimulated cells and cells stimulated with rmSCF (10 ng/mL) were precleared with protein G-Sepharose beads (Pharmacia) for 2 hours at 4°C. The precleared lysate was then incubated with ACK2 MoAb and protein G-Sepharose beads to collect antigen-antibody complex. The immunoprecipitates were washed five times with lysis buffer and subjected to SDS-PAGE with 5% to 20% gradient polyacrylamid. The proteins labeled by sulfo-NHS-biotin were electrophoretically transferred from the gel onto a polyvinylidine difluoride membrane, and the membrane was incubated with streptavidin-biotinylated horseradish-peroxidase complex (Amersham International plc, Buckinghamshire, UK) in PBS containing 0.5% bovine serum albumin (Sigma) and 0.05% Tween 20 for 1 hour. The labeled proteins were revealed with the enhanced chemiluminescence (ECL) Western blot detection system (Amersham International). The intensity of signals was measured by a Scanning Imager (Molecular Dynamics Inc, Sunnyvale, CA).
Transplanfation to nude mice. IC-2WT or IC-2FMA3 cells were harvested at an exponential phase of growth, washed, and resuspended in a-MEM. IC-2VECT0R cells were used as a negative control. Cells (3 X IO' ) were injected subcutaneously at the right and left flanks of nude athymic mice that had received whole body x-ray irradiation (2.5 Cy) 1 day before the injection. Mice were carefully monitored for development of palpable or visible tumors at the sites of the injection. The tumors were measured with a vernier caliper every 5 days. The tumor volume (V) was calculated with the formula, V = 0.5 X a X bZ, where a and b are the length and width in mm of the tumor mass, re~pectively.~~ Each tumor tissue was divided into three pieces. The first tumor piece was fixed by Carnoy's solution overnight and embedded in paraffin. The sections (4 pm thick) were histopathologically examined after staining with hematoxylin and eosin or with alcian blue and nuclear fast red. The second tumor piece was freshly covered with Tissue-Tek OCT compound (an embedding medium to freeze tissues, Miles Inc, Elkhalt, IN) and quickly frozen in liquid nitrogen; frozen sections (4 pm thick) were prepared with a cryostat. The section were fixed with ice-cold methanol-acetone (1 :l), washed in PBS and incubated with the ACK2 MoAb at the concentration of 10 & n L in PBS overnight at 4°C. The sections were then washed five times with PBS and incubated with the FITC-conjugated rabbit antirat IgG antibody (DAKO) for 40 minutes at 4"C, followed by extensive washing with PBS. The specimens were examined with a confocal laser scanning microscope (LSM-GM200, Olympus, Tokyo, Japan). The third tumor piece was snipped with forceps and gently homogenized in a loose fitting glass homogenizer containing a-MEM to obtain cell suspension. The cell suspension was incubated with the ACK2 MoAb and the FITC-conjugated rabbit antirat immunoglobulin antibody (DAKO), and then analyzed on a FACScan. was examined by flow cytometry using ACK2 MoAb. KIT was apparently expressed on the cell surface of FMA3 cells. Although the magnitude of KIT expression was comparable between +/+ CMCs and FMA3 cells (Fig IA) , +/+ CMCs, but not FMA3 cells, proliferated in a SCF-dependent manner (Fig 1 B) . We, therefore, examined the state of tyrosine phosphorylation of KIT in FMA3 cells before and after stimulation with rmSCF. Although tyrosine phosphorylation of KIT occurred only after treatment with rmSCF in +/+ CMCs, it occurred even before rmSCF treatment in FMA3 cells (Fig  2A) . We further examined the autokinase activity of KIT in (Fig 3) . In addition, three changes that might be caused by the strain-specific polymorwere observed in the c-kit cDNA sequence of FMA3 cells: an AT to CG transversion at nucleotide 648 that resulted in the amino acid substitution of Glu to Ala at codon 207; a CG to TA transition at nucleotide 1618 that did not induce alteration of amino acids; and a GCG codon at nucleotides 2357 to 2359 changed to a GGC codon, leading to the change from Ala to Gly at codon 777 (data not shown). We then examined whether the deletion was present on both c-kit alleles of FMA3 cells. Because the deletion of 21 bp were present on the exon 11 of mouse c-kit gene?' PCR analysis was performed on genomic DNA of FMA3 cells using primers 2 and 3. A band of 90 bp was detectable in PCR products from the genomic DNA of +/+ CMCs. In contrast, only a band of 69 bp was detected in PCR products from the genomic DNA of FMA3 cells (Fig 4) .
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PCR analysis of c-kit cDNA using the same primers also showed a band of 90 bp in +I+ CMCs and a band of 69 bp in FMA3 cells (Fig 4) . suggesting that only the c-kit allele with 21-bp deletion was transcribed in FMA3 cells.
When the c-kitwT cDNA and c-ki? cDNA were introduced into cells of the 293T human embryonic kidney cell line, KITFMA3 was constitutively phosphorylated on tyrosine residues and activated, whereas KITwT showed ligand-dependent tyrosine phosphorylation and activation (data not shown). These results indicated that the deletion mutation is responsible for the constitutive activation of K I T m 3 .
Retroviral transfer of KITFMA3 into an IL-3-dependent mast cell line. K-3-dependent IC-2 cells were chosen to KIT on the surface of infected cells was examined by flow cytometry using ACK2 MoAb. IC-2W' cells expressed KIT on the surface, whereas IC-2V"CT0K cells did not (Fig SA) . Surface expression of KIT was also detectable in IC-2'""' cells, although the magnitude of KIT expression was weaker when compared with IC-2"'.' cells (Fig SA) . In IC-2wT cells, tyrosine phosphorylation of KIT was barely detectable in the absence of rmSCF, but was significantly augmented by the rmSCF stirnulation (Fig SB) . On the other hand, an abundant tyrosine phosphorylation of KIT was observed in IC-2""" cells without the stimulation by rmSCF (Fig SB) .
We further examined the autokinase activity of KITWT
. KIT was immunoprecipitated from cell lysates before stimulation with rmSCF and was subjected to immune complex kinase assay. Comparable amounts of KIT were immunoprecipitated from both samples (data not shown). KIT''"A3 exhibited a striking tyrosine kinase activity, whereas tyrosine kinase activity of KIT"'" was barely detectable without the stimulation by SCF (Fig SC) . The receptor dimerization is known to be a key event in signal transduction. To determine whether KIT'""' led to receptor dimerization regardless of stirnulation with rmSCF, we performed cross-linking analysis of KITW' and KITvM"'. IC-2"T and FMA3 cells were used for the experiment because the expression of KIT'"' in IC-2WT cells was comparable to that of KIT"""3 in FMA3 cells (Figs I and S ) . In other words, the expression of KIT""*' in IC-2'""' cells was apparently lower when compared with that of KIT''"A' in FMA3 cells (Fig S ) . Cells were incubated with or without rmSCF (300 ng/mL) and treated with a cross-linker BS' that hardly enters the cytoplasm. rmSCF induced tyrosine phosphorylation of KITWT, and the phosphorylated form of KIT"" was detected in proteins at an approximate molecular mass of -330 kD that represented a cross-linked homodimer of KITWT-rmSCF complex (Fig 6) . By contrast, an abundant tyrosine phosphorylation of KIT' ""' was observed even without the rmSCF stimulation, and the phosphorylated form showed the size of -290 kD that may represent a crosslinked homodimer of KITF""' (Fig 6) . After the rmSCF stimulation, phosphorylated form of KITFM"' was detected in a molecular mass of -330 kD that represented a cross-linked homodimer of K1T'""'"rmSCF complex (Fig 6 ) . These results suggested that the deletion mutation at the juxtamembrane domain induced the dimerization of KIT without the rmSCF stimulation.
Because ligand-induced downregulation of receptors is known to serve as an attenuation mechanism for ligandmediated signaling, the elimination of internalization signal may cause the constitutive activation of KIT'MAZ. To examine whether the deletion found in KIT':""' resulted in the elimination of internalization signal, FMA3 cells were surface-labeled with sulfo-NHS-biotin and the labeled cells were incubated in the absence or presence of rmSCF. The amount of KIT that remained on the surface was assessed by immunoprecipitation and SDS-PAGE. Without rmSCF, the surface KIT"""' decreased only slightly within 60 minutes (Fig 7) . On the other hand, when FMA3 cells were incubated with rmSCF ( I O ng/mL), the surface KIT""" decreased remarkably within the first 15 minutes (Fig 7) .
K8cc-t ef KIT^^,^" expression on ,~lc-tor-inrI~perlrIi~lIt growth m r I tumorigcniciy. IC-2V""'K, IC-2W1, or ICcells were cultured with rmIL-3 or rmSCF of various concentrations for 72 hours, and their proliferation was measured with MTT colorimetric assay (Fig 8) . As proliferative response to rmSCF over the range of 1 to 1,000 ng/mL, indicating functional expression of KITWT. In contrast, IC-2FMA' cells proliferated without either rmIL-3 or rmSCF. In fact, the addition of rmIL-3 or rmSCF had a minimal effect on proliferation of IC-zFMA' cells.
1C-2VECT0R, IC-2WT, or IC-2FMA1 cells (3.0 X 10') were injected subcutaneously at the right and left flanks of nude athymic mice. IC-2VECroR cells did not yield any detectable tumors within a 6-week observation period. In contrast, ICnude mice succumbed to leukemia and died within 7 weeks. IC-2 cells kept in our laboratory had few alcian blue-positive granules in the suspension culture. IC-2FMA3 cells growing in the suspension culture had few alcian blue-positive granules as well (data not shown). In contrast, IC-2FMA3 cells growing in the subcutaneous tissue of nude mice contain alcian blue-positive granules, albeit the staining intensity was much weaker in these IC-2FMA3 cells than in by-standing mast cells, which might be of the host origin (Fig 10A, see  page 277 ). To examine whether IC-2FMA3 cells growing in the subcutaneous tissue of nude mice express KIT, immunohistochemistry and flow cytometry were done using ACK2 MoAb. Most IC-2FMA' cells growing in the subcutaneous 2FMA3 cells produced tumors at all injection sites (Fig 9) . All TSUJIMURA ET AL tissue contained immunoreactive KIT (Fig 10B, see page  277 ). The flow cytometry confirmed that the magnitude of surface KIT expression was comparable between IC-2FMA7 cells growing in the subcutaneous tissue and the IC-2FMA' cells growing in the suspension culture (data not shown).
Massive infiltration of IC-2FMA3 cells into the bone marrow, spleen, and liver was observed. In the nude mice injected with IC-2wT cells, no tumors were detectable within 3 weeks, but small nodules developed at three of 10 injection sites at day 25. However, leukemia did not develop, and all nude mice were alive within an 8-week observation period.
DISCUSSION
RTKs are known to control many aspects of normal cell growth and differentiation in both embryos and adults. In addition, it has become increasingly apparent that structural alterations, especially by dominant activating mutations, of RTKs such as neulc-erbB-2,5'-5' c-Jins,54-56 and can function as oncogenic proteins and play causal roles in cell transformation. Because KIT plays a fundamental role in proliferation and differentiation of hematopoietic stem cells and mast cells, it has been suggested that, if present, activating mutations of c-kit might be associated with neoplastic growth of hematopoietic cells including mast cells. Recently, we have provided unique evidence that constitutively activating mutations of c-kit is detectable in three different types of tumor mast cell lines. 2"2h In this study, we have shown additional data reinforcing the hypothesis that activating mutations of c-kit may be involved in development of mast cell tumors. In the FMA3 mastocytoma cell line, KIT was found to be phosphorylated on tyrosine residues and activated regardless of SCF stimulation. Sequencing analysis of the whole coding region of ckit showed that c-kit cDNA of FMA3 cells carried an in-frame deletion of 21 bp encoding Thr-Gln-Leu-Pro-TyrAsp-His at codons 573 to 579 in the juxtamembrane domain. When murine c-kitw or c-kifMAZ genes were introduced into cells of either the 293T human embryonic kidney cell line or the IC-2 murine IL-3-dependent mast cell line, KITFMA' was constitutively phosphorylated on tyrosine and activated, whereas KITWT showed tyrosine phosphorylation and activation in a ligand-dependent manner. Furthermore, retroviral transfer of KITFMA3 into IC-2 cells resulted in production of a factor-independent and tumorigenic phenotype. These results indicate that the in-frame deletion of c-kit found in FMA3 cells is a newly identified activating mutation, and the mutation converts KIT into an oncoprotein, capable of inducing neoplastic transformation of mast cells. 
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We examined the activation mechanism of KITmA3. KITmA3 was dimerized without the SCF binding, and moreover the dimerized K I T m A 3 was not internalized. There are two possibilities: (1) the deletion of seven amino acids in the juxtamembrane domain may cause a conformational change tuming on the kinase activity, and (2) the internalization signal may be eliminated due to the deletion, and the receptor may not be downregulated. These two possibilities are not mutually exclusive.
We have already described that a point mutation of c-kit, the substitution of Val to Gly at codon 559 in the juxtamembrane domain, led to constitutive dimerization and activation of (Fig 11) .24.27 Despite limited information available for the activating mutations in the juxtamembrane domain of c-kit, deletion of Ty869 and Val570 codons in the juxtamembrane domain of feline c-kit, corresponding to Ty867 and Vals6* codons in murine c-kit, was reported to enhance transforming and mitogenic activities of the KIT (Fig 11) .@' In contrast, the Gld8* to Lys (Wj7) substitution in the juxtamembrane domain of murine c-kit is known to produce unstable KIT and impair tyrosine kinase activity.61.62 Thus, it is likely that the juxtamembrane domain of c-kit may possess a variety of functional sites that play a potentially pivotal role for regulating tyrosine kinase activity of the receptor.
Interestingly, the seven amino acid sequence (Thr-GlnLeu-Pro-Tyr-Asp-His) that is deleted in the juxtamembrane domain of KITFMA3 is widely conserved in all of mouse,' cat,@' cattle,@ human: and chicked5 KITS. Furthermore, the four amino acid sequence Gln-Leu-Pro-Tyr within the seven amino acid sequence is entirely conserved in type I11 RTKs such as KIT, PDGF receptor,= and CSF-I receptor67 (Fig 11) . Therefore, it is possible that the deleted region of KITmA3 may have an important role on the structure and function of type 111 RTKs. Using a variety of CSF-l receptor mutants, Myles et a16* suggested that the four amino acid sequence, particularly Ty869 residue (corresponding to Ty877 of KIT), might play a dual role for both internalization and tyrosine kinase activity of the receptor. They reported that the Ty869 to Ala substitution, as well as deletion mutants lacking sequences around Ty869, eliminated ligand-induced endocytosis and abolished tyrosine kinase activity of CSF-1 receptor. They also showed that the four amino acid sequence could support endocytosis when transferred into the juxtamembrane region of a glycophorin A construct. 65 In the case of KIT, however, the deletion of the seven amino acid sequence resulted in constitutive activation of the receptor without internalization, suggesting that the deleted region of KIT appear to be involved in negative regulation of kinase activity.
Taken together, the results presented here show that a novel in-flame deletion of c-kit gene identified in the mouse FMA3 mastocytoma cell line has an oncogenic activity. However, the precise mechanisms by which the in-flame deletion of c-kit induces constitutive activation of KIT and transmits oncogenic signals into cells await further studies.
Detailed knowledge about such mechanisms should be useful not only to create a model for RTK signaling, but also to understand normal and abnormal growth of hematopoietic stem cells and mast cells.
only.
